Omnicell
OMCL
397 hedge funds and large institutions have $5.84B invested in Omnicell in 2022 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 164 increasing their positions, 136 reducing their positions, and 65 closing their positions.
98% more call options, than puts
Call options by funds: $4.92M | Put options by funds: $2.49M
21% more repeat investments, than reductions
Existing positions increased: 164 | Existing positions reduced: 136
0.18% less ownership
Funds ownership: 104.25% → 104.06% (-0.18%)
6% less funds holding
Funds holding: 422 → 397 (-25)
28% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 65
29% less capital invested
Capital invested by funds: $8.25B → $5.84B (-$2.41B)
42% less funds holding in top 10
Funds holding in top 10: 12 → 7 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$62.4M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$52.9M |
| 3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$33.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$32.4M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$30.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$68.2M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$53.4M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$38.9M |
| 4 |
SG Americas Securities
New York
|
-$32.2M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$30.7M |
OMCL Hedge Fund Activity: Q1 2022 in Review
397 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q1 2022, worth a combined $5.84B — down 29% from $8.25B a quarter earlier.
Sellers outnumbered buyers: 65 funds closed out of OMCL and 47 opened new positions — a net loss of 18 holders — while 136 trimmed existing stakes and 164 added.
The largest buyer was BlackRock, adding an estimated $62.4M. The largest seller was Victory Capital Management, cutting an estimated $68.2M.
- 397 institutional investors held Omnicell (OMCL) as of Q1 2022, down from 422 in Q4 2021.
- Funds reported $5.84B of Omnicell stock for Q1 2022, down 29% quarter-over-quarter.
- 47 funds opened new Omnicell positions in Q1 2022 and 65 closed out, a net change of -18 holders.
- The largest Omnicell buyer in Q1 2022 was BlackRock, an estimated $62.4M added.
- The largest Omnicell seller in Q1 2022 was Victory Capital Management, an estimated $68.2M sold.
Based on aggregated 13F filings for Q1 2022.